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Introduction 
 
The recent emergence of the novel coronavirus disease of 2019 (COVID-19) in Wuhan, 
China and its rapid spread across the world has posed a global health emergency. Scientists and 
researchers across the world are working together to improve the methods of detection and 
generate a vaccine that will cure the disease. However, in order to develop therapeutic strategies 
and techniques for the treatment of COVID-19, the structure of SARS-CoV-2 must be entirely 
scrutinized and comprehended. This review illustrates the similarities and differences between 
SARS-CoV-2 and other coronaviruses, while also indicating why the development of this lethal 
viral RNA can only be a result of natural evolution.  
 
1. Spike Protein Structure 
 
Coronaviruses (CoVs) are large enveloped viruses with a positive single-stranded RNA 
genome. They belong to the subfamily Coronavirinae within the family Coronaviridae, which is 
part of the Nidovirales order, and can be classified into four 
genera: Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus. Among 
all CoVs identified so far, seven have the ability to infect humans, including human coronavirus 
229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63), which belong to alpha-CoVs1, as 
well as human coronavirus OC43 (HCoV-OC43), human coronavirus HKU1 (HCoV-HKU1), severe 
acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome 
coronavirus (MERS-CoV), and the newly emerged coronavirus (2019-nCoV), which are known to 
be beta-CoVs and are the focus of this study (Figure 1)2. 
 
 Coronaviruses have the largest genome among all RNA viruses, typically ranging from 27 
to 32 kb3. The genetic material of the virus is packed inside a helical capsid formed by the 
nucleocapsid protein (N) and further enclosed by an envelope that contains: the membrane 
protein (M) and the envelope protein (E), which are essential for cellular assembly, and the spike 
protein (S), which mediates virus entry into the host cells and therefore is the viral protein of 
interest of most scientific studies3. As explained in the literature, S is a viral fusion protein that 
promotes host attachment and synthesis of the membranes during entry4. Due to these qualities, 
S determines host range and cell tropism which differs significantly among coronaviruses and 
serves as the main point for comparison among the viruses. The S protein has been intensely 
scrutinized by scientists and researchers from all over the globe as it is the distinguishing feature 
that can be used to characterize coronaviruses; therefore, it will be a point of focus. 
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Figure 1. Classification of Coronaviruses. Representative coronaviruses in each genus are HCoV-229E and HCoV-
NL63 for the genus Alphacoronavirus. SARS-CoV, MERS-CoV, and SARS-CoV-2 for the genus Betacoronavirus. AIBV 
for the genus Gammacoronavirus. PdCV for the genus Deltacoronavirus.  
 
According to a study conducted in 2016, the coronavirus spike protein contains three 
segments: an ectodomain with a receptor-binding subunit S1 and a membrane-fusion subunit S2, 
a single-pass transmembrane anchor, and a short intracellular tail5. Electron microscopy 
experiments done by this same study revealed that the spike is a clove-shaped trimer with three 
S1 units and a trimeric S2 unit5. When entering the host cell, S1 of the virus binds to a receptor 
on the host cell surface for viral attachment, and the S2 unit assists with fusion between the host 
and viral membranes, allowing the viral genetic material to penetrate and enter host cells3.  
However, this binding interaction differs among the multiple coronaviruses. According to a recent 
study, the receptor-binding S protein of SARS-CoV-2 encoded by the S gene was highly divergent 
from other CoVs, with less than 75% nucleotide sequence identity to all SARSr-CoVs, except for a 
93.1% nucleotide identity to RaTG136. As portrayed in the results, the S genes of 2019-nCoV and 
RaTG13 are longer than the other SARSr-CoVs. The three short insertions in the N-terminal 
domain and differences in four out of the five key residues in the receptor binding motif (RBM) 
region is what distinguishes the S gene of SARS-CoV-2 from the sequence of SARS-CoV and makes 
the novel COVID-19 exceptional6.  
 
2. Receptor Binding Domains and Receptor Binding Motifs  
 
Although the receptor binding domains (RBDs) among the Betacoronaviruses are very 
similar, their receptor binding motifs (RBMs) differ. This explains why coronaviruses identify 
different receptors and attack their targeted cells uniquely. Similar to HCoV-NL632, SARS-CoV and 
SARS-CoV-2 recognize the angiotensin-converting enzyme 2 (ACE2) as the receptor on the host 
cell through the RBD (CTP) region of its S1 unit7, while MERS-CoV utilizes dipeptidyl peptidase 4 
(DPP4) as a receptor through the RBD (CTD) region8. Not all coronaviruses attach to the host cells 
through the same receptors; it has been identified that the ACE2 is the preferred binding 
Seton Hall Biochemistry II Annals of Student Reviews                                                                                                
Vol 1. No. 1 
2020 
 
3 
 
structure of SARS-CoV and SARS-CoV-2, which differs from the other mechanisms of viral 
attachment and entry exhibited by other viruses. 
 
The genome of SARS-CoV-2 encodes pp1a and pp1ab, and eight accessory proteins along 
with the four main proteins previously discussed9 The MERS-CoV genome is about 30 kb in length 
and encodes pp1a, pp1ab and five accessory proteins along with the four main proteins10. Recent 
studies have found that SARS-CoV-2 virus is 79.5% identical to the sequence found in SARS-CoV6 
as it encodes pp1ab, and six accessory proteins along with the four main proteins. The similarity 
in structure and sequence supports the hypothesis that SARS-CoV-2 evolved from SARS-CoV RBDs 
in an attempt to improve binding affinity to the same ACE2 receptor11; however, the two viruses 
differ in their receptor binding motifs.  
 
Structural studies have shown SARS-CoV-2 RBD has a unique Lys417 residue on its RBM 
region that forms salt-bridge interactions with the Asp30 in the ACE2 of its target cells; on the 
other hand, SARS-CoV lacks this amino acid and instead it has a valine residue that does not 
participate in ACE2 binding11. This lysine residue gives a positive-charged region on the SARS-
CoV-2 RBD that is absent on the SARS-CoV RBD, an alteration that influences the binding affinity 
difference of the SARS-CoV-2 and SARS-CoV to the ACE2 receptor11. Although these studies were 
able to identify some residues that are potentially involved in the SARS-CoV-2-ACE2 interaction, 
the actual interaction remains elusive because computer modelling of the RBD, particularly for 
the RBM, appeared incomplete when a single spike protein was investigated11. Even though 
scientists have yet to crystallize the structure of the RBM in the SARS-CoV-2 RBD and the 
interaction still remains elusive, these findings illustrating the sequence similarities and 
discrepancies between SARS-CoV and SARS-CoV-2 will serve as a foundation for the development 
of the crystal structure of this region.  
 
Not only does the evolution of the receptor binding motif distinguishes SARS-CoV-2 from 
any other coronavirus, but it also provides an account to counteract previous claims that the viral 
RNA was genetically modified in a laboratory. Early papers regarding the origin of the virus 
suggested that four insertions in the S protein of SARS-CoV-2 resembled amino acid residues in 
key structural proteins of HIV, the virus that causes AIDS12. These premature theories led to the 
speculation that 2019-nCoV had been genetically modified in the lab to use as a bioweapon, 
causing controversy within the scientific community. Most researchers believe that the 
experiments that suggest that the development of SARS-CoV-2 could not have been fortuitous in 
nature were rushed and provided miscalculated results. To be able to claim that 2019-nCoV 
derived from gene fragments of HIV-1, both viruses would need to co-infect the same cells. 
However, the host cells for bat CoV and HIV-1 are different, and therefore it is high unlikely that 
they exchange genetic material13. 
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Conclusions 
 
Despite the conspiracy theories circulating the origin of the virus, the scientific data 
illustrated in this review shows that the development of SARS-CoV-2 was a result of natural 
selection and not of purposeful manipulation. This review goes into detail regarding the 
structural comparison between 2019-nCoV and other coronaviruses, the genetic make-up 
discussed in here shows that SARS-CoV-2 has components that differ significantly from other 
known viruses. These discrepancies reduce the possibility of a man-made virus because these 
structures have not been identified in other viral RNAs, which demonstrates that SARS-CoV-2 is 
not derived from any previous used virus backbone and therefore is a product of nature itself 
and evolution. Nonetheless, further analysis of the viral structure needs to be accomplished to 
develop a successful and efficient therapeutic treatment for COVID-19. All of the scientific papers 
cited in this report offer valuable information regarding the similarities and differences between 
SARS-CoV-2 and other coronaviruses and establish the foundation of the assembly of the virus 
that may be used in future works to crystallize the final structure of the virus in its entirety. 
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